Massachusetts Financial Services’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Buy |
169,259
+2,091
| +1% | +$16.9K | ﹤0.01% | 792 |
|
|
2025
Q1 | $1.4M | Sell |
167,168
-3,810
| -2% | -$31.9K | ﹤0.01% | 784 |
|
|
2024
Q4 | $1.35M | Sell |
170,978
-19,684
| -10% | -$156K | ﹤0.01% | 787 |
|
|
2024
Q3 | $1.59M | Sell |
190,662
-4,617
| -2% | -$38.4K | ﹤0.01% | 752 |
|
|
2024
Q2 | $1.24M | Sell |
195,279
-26,528
| -12% | -$168K | ﹤0.01% | 781 |
|
|
2024
Q1 | $1.34M | Buy |
+221,807
| New | +$1.34M | ﹤0.01% | 758 |
|
|
2022
Q2 | – | Sell |
-79,942
| Closed | -$333K | – | 848 |
|
|
2022
Q1 | $333K | Buy |
79,942
+819
| +1% | +$3.41K | ﹤0.01% | 840 |
|
|
2021
Q4 | $379K | Sell |
79,123
-1,602
| -2% | -$7.67K | ﹤0.01% | 867 |
|
|
2021
Q3 | $431K | Sell |
80,725
-1,059
| -1% | -$5.65K | ﹤0.01% | 882 |
|
|
2021
Q2 | $419K | Buy |
81,784
+700
| +0.9% | +$3.59K | ﹤0.01% | 884 |
|
|
2021
Q1 | $546K | Sell |
81,084
-9,611
| -11% | -$64.7K | ﹤0.01% | 878 |
|
|
2020
Q4 | $414K | Buy |
+90,695
| New | +$414K | ﹤0.01% | 849 |
|
|
2018
Q3 | – | Sell |
-89,933
| Closed | -$1.48M | – | 853 |
|
|
2018
Q2 | $1.48M | Buy |
+89,933
| New | +$1.48M | ﹤0.01% | 738 |
|